1 September 2014 – Craneware (AIM: CRW.L), announces that it has issued and allotted 211,539 ordinary shares of 1p each as vendor consideration in connection with the acquisition of Kestros Limited.
Application has been made to the London Stock Exchange for the shares to be admitted to trading on AIM and it is expected that admission will become effective on 03 September 2014.
Following this notification, the Company has 26,826,486 Ordinary Shares in issue.
For further information, please contact:
- +44 (0) 20 7418 8900
- Dan Webster
- Richard Kauffer
- +44 (0) 20 7653 9850
- Caroline Forde
- Fiona Conroy
- Heather Armstrong
Founded in 1999, Craneware has headquarters in Edinburgh, Scotland with offices in Atlanta, Arizona, Massachusetts and Tennessee employing over 200 staff. Craneware is the leader in automated revenue integrity solutions that improve financial performance for healthcare organisations. Craneware’s market-driven, SaaS solutions help hospitals and other healthcare providers more effectively price, charge, code and retain earned revenue for patient care services and supplies. This optimises reimbursement, increases operational efficiency and minimises compliance risk. By partnering with Craneware, clients achieve the visibility required to identify, address and prevent revenue leakage. To learn more, visit craneware.com.